Insulin glargine and lixisenatide and Latanoprost and Timolol
Determining the interaction of Insulin glargine and lixisenatide and Latanoprost and Timolol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: latanoprost / timolol ophthalmic
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Latanoprost Eye Drops (Emulsion)
- Insulin glargine and lixisenatide-Latanoprost Eye Drops (Solution)
- Insulin glargine and lixisenatide-Latanoprost ophthalmic
- Insulin glargine and lixisenatide-Latanoprost Ophthalmic Solution
- Insulin glargine and lixisenatide-Latanoprostene Bunod
- Insulin glargine and lixisenatide-Latanoprostene bunod ophthalmic
- Latanoprost and Timolol-Insulin glargine and lixisenatide Subcutaneous
- Latanoprost and Timolol-Insulin glargine, recombinant Subcutaneous
- Latanoprost and Timolol-Insulin glulisine
- Latanoprost and Timolol-Insulin Glulisine (Cartridges and Pens)
- Latanoprost and Timolol-Insulin Glulisine (Vials)
- Latanoprost and Timolol-Insulin glulisine Subcutaneous